133 related articles for article (PubMed ID: 1982612)
21. Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation.
Chilian WM
Circulation; 1991 Nov; 84(5):2108-22. PubMed ID: 1682067
[TBL] [Abstract][Full Text] [Related]
22. How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?
Jost S; Nolte CW; Sturm M; Hausleiter J; Hausmann D
Int J Card Imaging; 1998 Dec; 14(6):357-72. PubMed ID: 10453390
[TBL] [Abstract][Full Text] [Related]
23. Sympathetic coronary vasoconstriction after adrenergic beta blockade.
Kuramoto K; Murata K; Fujii J; Kurihara H; Kimata S
Tohoku J Exp Med; 1967 Jan; 91(1):95-101. PubMed ID: 6050303
[No Abstract] [Full Text] [Related]
24. Coronary vasomotor response to phenylephrine in heart transplant patients.
Aptecar E; Le Corvoisier P; Teiger E; Dupouy P; Vermes E; Sediame S; Hittinger L; Loisance D; Dubois-Rande JL; Montagne O
J Heart Lung Transplant; 2006 Aug; 25(8):912-20. PubMed ID: 16890111
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effect of beta adrenergic antagonists with different ancillary properties on isolated canine and human coronary arteries.
Berkenboom G; Fontaine J; Desmet JM; Degre S
Cardiovasc Res; 1987 Apr; 21(4):299-304. PubMed ID: 2888534
[TBL] [Abstract][Full Text] [Related]
26. Adrenergic coronary tone during submaximal exercise in the dog is produced by circulating catecholamines. Evidence for adrenergic denervation supersensitivity in the myocardium but not in coronary vessels.
Chilian WM; Harrison DG; Haws CW; Snyder WD; Marcus ML
Circ Res; 1986 Jan; 58(1):68-82. PubMed ID: 3002658
[TBL] [Abstract][Full Text] [Related]
27. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium.
Zeiher AM; Drexler H; Wollschlaeger H; Saurbier B; Just H
J Am Coll Cardiol; 1989 Nov; 14(5):1181-90. PubMed ID: 2808971
[TBL] [Abstract][Full Text] [Related]
28. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
29. Endothelin antagonists block alpha1-adrenergic constriction of coronary arterioles.
DeFily DV; Nishikawa Y; Chilian WM
Am J Physiol; 1999 Mar; 276(3):H1028-34. PubMed ID: 10070088
[TBL] [Abstract][Full Text] [Related]
30. Alpha- and beta-adrenergic control of large coronary arteries in conscious calves.
Young MA; Vatner DE; Vatner SF
Basic Res Cardiol; 1990; 85 Suppl 1():97-109. PubMed ID: 1982613
[TBL] [Abstract][Full Text] [Related]
31. Acute effects of celiprolol on angiographically normal and stenotic coronary arteries.
Jost S; Hausmann D; Lippolt P; Sturm M
Cardiovasc Drugs Ther; 1997 Apr; 11(2):133-8. PubMed ID: 9140690
[TBL] [Abstract][Full Text] [Related]
32. Autonomic control of large coronary arteries and resistance vessels.
Young MA; Knight DR; Vatner SF
Prog Cardiovasc Dis; 1987; 30(3):211-34. PubMed ID: 2823312
[TBL] [Abstract][Full Text] [Related]
33. Effect of atenolol and pindolol on the phorbol ester-induced coronary vasoconstriction in the isolated perfused heart of the rat.
Ruskoaho H
Br J Pharmacol; 1988 Jun; 94(2):573-83. PubMed ID: 2840163
[TBL] [Abstract][Full Text] [Related]
34. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension.
Frielingsdorf J; Seiler C; Kaufmann P; Vassalli G; Suter T; Hess OM
Circulation; 1996 Apr; 93(7):1380-7. PubMed ID: 8641027
[TBL] [Abstract][Full Text] [Related]
35. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward beta-adrenergic control.
Duncker DJ; Stubenitsky R; Verdouw PD
Circ Res; 1998 Jun; 82(12):1312-22. PubMed ID: 9648728
[TBL] [Abstract][Full Text] [Related]
36. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.
Gregorini L; Fajadet J; Robert G; Cassagneau B; Bernis M; Marco J
Circulation; 1994 Aug; 90(2):895-907. PubMed ID: 8044961
[TBL] [Abstract][Full Text] [Related]
37. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
38. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
Barbato E; Piscione F; Bartunek J; Galasso G; Cirillo P; De Luca G; Iaccarino G; De Bruyne B; Chiariello M; Wijns W
Circulation; 2005 Jan; 111(3):288-94. PubMed ID: 15642763
[TBL] [Abstract][Full Text] [Related]
39. Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
Drieu la Rochelle C; Berdeaux A; Richard V; Giudicelli JF
J Cardiovasc Pharmacol; 1991 Dec; 18(6):904-10. PubMed ID: 1725905
[TBL] [Abstract][Full Text] [Related]
40. Ghrelin Preserves Ischemia-Induced Vasodilation of Male Rat Coronary Vessels Following β-Adrenergic Receptor Blockade.
Pearson JT; Collie N; Lamberts RR; Inagaki T; Yoshimoto M; Umetani K; Davis P; Wilkins G; Jones PP; Shirai M; Schwenke DO
Endocrinology; 2018 Apr; 159(4):1763-1773. PubMed ID: 29325034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]